Analysis of the small RNA transcriptional response in multidrug-resistant staphylococcus aureus after antimicrobial exposure

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 8, 2013, Pages 3864-3874

  Howden, Benjamin P ^a,b,c   Beaume, Marie ^d   Harrison, Paul F ^c   Hernandez, David ^d   Schrenzel, Jacques ^d   Seemann, Torsten ^c   Francois, Patrice ^d   Stinear, Timothy P ^b,c  

^a AUSTIN HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTOBIPROLE; LINEZOLID; MESSENGER RNA; SMALL UNTRANSLATED RNA; TIGECYCLINE; VANCOMYCIN;

ANALYTIC METHOD; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; EXPOSURE; MULTIDRUG RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; NONNEGATIVE MATRIX FACTORIZATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RNA SEQUENCE; RNA TRANSCRIPTION; STAPHYLOCOCCUS AUREUS; VANCOMYCIN INTERMEDIATE STAPHYLOCOCCUS AUREUS; VANCOMYCIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS;

ACETAMIDES; ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; OXAZOLIDINONES; PROTEIN BIOSYNTHESIS; RNA, BACTERIAL; RNA, MESSENGER; RNA, SMALL UNTRANSLATED; SEQUENCE ANALYSIS, RNA; TRANSCRIPTION, GENETIC; VANCOMYCIN;

EID: 84880279404     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00263-13     Document Type: Article

References (53)

1. Turnidge JD, Kotsanas D, Munckhof W, Roberts S, Bennett CM, Nimmo GR, Coombs GW, Murray RJ, Howden B, Johnson PD, Dowling K. 2009. Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand. Med. J. Aust. 191:368-373.
2. Howden BP, Davies JK, Johnson PD, Stinear TP, Grayson ML. 2010. Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. Clin. Microbiol. Rev. 23:99-139.
3. Coombs GW, Nimmo GR, Bell JM, Huygens F, O'Brien FG, Malkowski MJ, Pearson JC, Stephens AJ, Giffard PM. 2004. Genetic diversity among community methicillin-resistant Staphylococcus aureus strains causing outpatient infections in Australia. J. Clin. Microbiol. 42:4735-4743.
4. Nimmo GR, Pearson JC, Collignon PJ, Christiansen KJ, Coombs GW, Bell JM, McLaws ML. 2007. Prevalence of MRSA among Staphylococcus aureus isolated from hospital inpatients, 2005: report from the Australian Group for Antimicrobial Resistance. Commun. Dis. Intell. 31:288-296.
5. Harris SR, Feil EJ, Holden MT, Quail MA, Nickerson EK, Chantratita N, Gardete S, Tavares A, Day N, Lindsay JA, Edgeworth JD, de Lencastre H, Parkhill J, Peacock SJ, Bentley SD. 2010. Evolution of MRSA during hospital transmission and intercontinental spread. Science 327: 469-474.
6. Howden BP, Seemann T, Harrison PF, McEvoy CR, Stanton JA, Rand CJ, Mason CW, Jensen SO, Firth N, Davies JK, Johnson PD, Stinear TP. 2010. Complete genome sequence of Staphylococcus aureus strain JKD6008, an ST239 clone of methicillin-resistant Staphylococcus aureus with intermediate-level vancomycin resistance. J. Bacteriol. 192:5848-5849.
7. Wassarman KM. 2002. Small RNAs in bacteria: diverse regulators of gene expression in response to environmental changes. Cell 109:141-144.
8. Chabelskaya S, Gaillot O, Felden B. 2010. A Staphylococcus aureus small RNA is required for bacterial virulence and regulates the expression of an immune-evasion molecule. PLoS Pathog. 6:e1000927. doi:10.1371/journal.ppat. 1000927.
9. Sayed N, Jousselin A, Felden B. 2012. A cis-antisense RNA acts in trans in Staphylococcus aureus to control translation of a human cytolytic peptide. Nat. Struct. Mol. Biol. 19:105-112.
10. Gottesman S, Storz G. 2011. Bacterial small RNA regulators: versatile roles and rapidly evolving variations. Cold Spring Harb. Perspect. Biol. 3:a003798. doi:10.1101/cshperspect.a003798.
11. Geissmann T, Chevalier C, Cros MJ, Boisset S, Fechter P, Noirot C, Schrenzel J, Francois P, Vandenesch F, Gaspin C, Romby P. 2009. A search for small noncoding RNAs in Staphylococcus aureus reveals a conserved sequence motif for regulation. Nucleic Acids Res. 37:7239-7257.
12. Marchais A, Naville M, Bohn C, Bouloc P, Gautheret D. 2009. Singlepass classification of all noncoding sequences in a bacterial genome using phylogenetic profiles. Genome Res. 19:1084-1092.
13. Livny J, Waldor MK. 2007. Identification of small RNAs in diverse bacterial species. Curr. Opin. Microbiol. 10:96-101.
14. Pichon C, Felden B. 2005. Small RNA genes expressed from Staphylococcus aureus genomic and pathogenicity islands with specific expression among pathogenic strains. Proc. Natl. Acad. Sci. U. S. A. 102:14249-14254.
15. Sharma CM, Vogel J. 2009. Experimental approaches for the discovery and characterization of regulatory small RNA. Curr. Opin. Microbiol. 12:536-546.
16. Beaume M, Hernandez D, Farinelli L, Deluen C, Linder P, Gaspin C, Romby P, Schrenzel J, Francois P. 2010. Cartography of methicillinresistant S. aureus transcripts: detection, orientation and temporal expression during growth phase and stress conditions. PLoS One 5:e10725. doi: 10.1371/journal.pone.0010725.
17. Novick RP, Ross HF, Projan SJ, Kornblum J, Kreiswirth B, Moghazeh S. 1993. Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule. EMBO J. 12:3967-3975.
18. Bohn C, Rigoulay C, Chabelskaya S, Sharma CM, Marchais A, Skorski P, Borezee-Durant E, Barbet R, Jacquet E, Jacq A, Gautheret D, Felden B, Vogel J, Bouloc P. 2010. Experimental discovery of small RNAs in Staphylococcus aureus reveals a riboregulator of central metabolism. Nucleic Acids Res. 38:6620-6636.
19. Yu J, Schneiders T. 2012. Tigecycline challenge triggers sRNA production in Salmonella enterica serovar Typhimurium. BMC Microbiol. 12:195. doi:10.1186/1471-2180-12-195.
20. Howden BP, Johnson PD, Ward PB, Stinear TP, Davies JK. 2006. Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob. Agents Chemother. 50:3039-3047.
21. Howden BP, Stinear TP, Allen DL, Johnson PD, Ward PB, Davies JK. 2008. Genomic analysis reveals a point mutation in the two-component sensor gene graS that leads to intermediate vancomycin resistance in clinical Staphylococcus aureus. Antimicrob. Agents Chemother. 52:3755-3762.
22. Lee DD, Seung HS. 1999. Learning the parts of objects by non-negative matrix factorization. Nature 401:788-791.
23. Brunet JP, Tamayo P, Golub TR, Mesirov JP. 2004. Metagenes and molecular pattern discovery using matrix factorization. Proc. Natl. Acad. Sci. U. S. A. 101:4164-4169.
24. Devarajan K. 2008. Nonnegative matrix factorization: an analytical and interpretive tool in computational biology. PLoS Comput. Biol. 4:e1000029. doi:10.1371/journal.pcbi.1000029.
25. Gaujoux R, Seoighe C. 2012. Semi-supervised nonnegative matrix factorization for gene expression deconvolution: a case study. Infect. Genet. Evol. 12:913-921.
26. McCallum N, Spehar G, Bischoff M, Berger-Bachi B. 2006. Strain dependence of the cell wall-damage induced stimulon in Staphylococcus aureus. Biochim. Biophys. Acta 1760:1475-1481.
27. Kuroda M, Kuroda H, Oshima T, Takeuchi F, Mori H, Hiramatsu K. 2003. Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus. Mol. Microbiol. 49:807-821.
28. Jousselin A, Kelley WL, Barras C, Lew DP, Renzoni A. 29 April 2013. The Staphylococcus aureus thiol/oxidative stress global regulator Spx controls trfA, a gene implicated in cell-wall antibiotic resistance. Antimicrob. Agents Chemother. doi:10.1128/AAC.00220-13.
29. Li H, Ruan J, Durbin R. 2008. Mapping short DNA sequencing reads and calling variants using mapping quality scores. Genome Res. 18:1851-1858.
30. David M, Dzamba M, Lister D, Ilie L, Brudno M. 2011. SHRiMP2: sensitive yet practical SHort Read Mapping. Bioinformatics 27:1011-1012.
31. Nawrocki EP, Kolbe DL, Eddy SR. 2009. Infernal 1.0: inference of RNA alignments. Bioinformatics 25:1335-1337.
32. Gardner PP, Daub J, Tate JG, Nawrocki EP, Kolbe DL, Lindgreen S, Wilkinson AC, Finn RD, Griffiths-Jones S, Eddy SR, Bateman A. 2009. Rfam: updates to the RNA families database. Nucleic Acids Res. 37:D136-D140.
33. Carver T, Harris SR, Otto TD, Berriman M, Parkhill J, McQuillan JA. 16 January 2012, posting date. BamView: visualizing and interpretation of next-generation sequencing read alignments. Brief. Bioinform. doi:10 .1093/bib/bbr073.
34. Rutherford K, Parkhill J, Crook J, Horsnell T, Rice P, Rajandream MA, Barrell B. 2000. Artemis: sequence visualization and annotation. Bioinformatics 16:944-945.
35. Robinson JT, Thorvaldsdottir H, Winckler W, Guttman M, Lander ES, Getz G, Mesirov JP. 2011. Integrative genomics viewer. Nat. Biotechnol. 29:24-26.
36. Robinson MD, McCarthy DJ, Smyth GK. 2010. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26:139-140.
37. Ritchie ME, Diyagama D, Neilson J, van Laar R, Dobrovic A, Holloway A, Smyth GK. 2006. Empirical array quality weights in the analysis of microarray data. BMC Bioinformatics 7:261. doi:10.1186/1471-2105-7-261.
38. Lee DD, Seung HS. 2001. Algorithms for non-negative matrix factorization, p 556-562. In Advances in Neural Information Processing Systems 13: Proceedings of the 2000 Conference. MIT Press, Cambridge, MA.
39. Gaujoux R, Seoighe C. 2010. A flexible R package for nonnegative matrix factorization. BMC Bioinformatics 11:367. doi:10.1186/1471-2105-11-367.
40. Howden BP, McEvoy CR, Allen DL, Chua K, Gao W, Harrison PF, Bell J, Coombs G, Bennett-Wood V, Porter JL, Robins-Browne R, Davies JK, Seemann T, Stinear TP. 2011. Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR. PLoS Pathog. 7:e1002359. doi:10.1371/journal.ppat.1002359.
41. Lasa I, Toledo-Arana A, Dobin A, Villanueva M, de los Mozos IR, Vergara-Irigaray M, Segura V, Fagegaltier D, Penades JR, Valle J, Solano C, Gingeras TR. 2011. Genome-wide antisense transcription drives mRNA processing in bacteria. Proc. Natl. Acad. Sci. U. S. A. 108: 20172-20177.
42. Sharma CM, Hoffmann S, Darfeuille F, Reignier J, Findeiss S, Sittka A, Chabas S, Reiche K, Hackermuller J, Reinhardt R, Stadler PF, Vogel J. 2010. The primary transcriptome of the major human pathogen Helicobacter pylori. Nature 464:250-255.
43. McAleese F, Wu SW, Sieradzki K, Dunman P, Murphy E, Projan S, Tomasz A. 2006. Overexpression of genes of the cell wall stimulon in clinical isolates of Staphylococcus aureus exhibiting vancomycinintermediate-S. aureus-type resistance to vancomycin. J. Bacteriol. 188: 1120-1133.
44. Utaida S, Dunman PM, Macapagal D, Murphy E, Projan SJ, Singh VK, Jayaswal RK, Wilkinson BJ. 2003. Genome-wide transcriptional profiling of the response of Staphylococcus aureus to cell-wall-active antibiotics reveals a cell-wall-stress stimulon. Microbiology 149:2719-2732.
45. Waters LS, Storz G. 2009. Regulatory RNAs in bacteria. Cell 136:615-628.
46. Pietiainen M, Francois P, Hyyrylainen HL, Tangomo M, Sass V, Sahl HG, Schrenzel J, Kontinen VP. 2009. Transcriptome analysis of the responses of Staphylococcus aureus to antimicrobial peptides and characterization of the roles of vraDE and vraSR in antimicrobial resistance. BMC Genomics 10:429. doi:10.1186/1471-2164-10-429.
47. Scherl A, Francois P, Charbonnier Y, Deshusses JM, Koessler T, Huyghe A, Bento M, Stahl-Zeng J, Fischer A, Masselot A, Vaezzadeh A, Galle F, Renzoni A, Vaudaux P, Lew D, Zimmermann-Ivol CG, Binz PA, Sanchez JC, Hochstrasser DF, Schrenzel J. 2006. Exploring glycopeptide-resistance in Staphylococcus aureus: a combined proteomics and transcriptomics approach for the identification of resistance-related markers. BMC Genomics 7:296. doi:10.1186/1471-2164-7-296.
48. Howden BP, Smith DJ, Mansell A, Johnson PD, Ward PB, Stinear TP, Davies JK. 2008. Different bacterial gene expression patterns and attenuated host immune responses are associated with the evolution of low-level vancomycin resistance during persistent methicillin-resistant Staphylococcus aureus bacteraemia. BMC Microbiol. 8:39. doi:10.1186/1471-2180-8-39.
49. Felden B, Vandenesch F, Bouloc P, Romby P. 2011. The Staphylococcus aureus RNome and its commitment to virulence. PLoS Pathog. 7:e1002006. doi:10.1371/journal.ppat.1002006.
50. Blount KF, Breaker RR. 2006. Riboswitches as antibacterial drug targets. Nat. Biotechnol. 24:1558-1564.
51. Blount KF, Wang JX, Lim J, Sudarsan N, Breaker RR. 2007. Antibacterial lysine analogs that target lysine riboswitches. Nat. Chem. Biol. 3:44-
52. Mulhbacher J, Brouillette E, Allard M, Fortier LC, Malouin F, Lafontaine DA. 2010. Novel riboswitch ligand analogs as selective inhibitors of guanine-related metabolic pathways. PLoS Pathog. 6:e1000865. doi:10 .1371/journal.ppat.1000865.
53. Olson PD, Kuechenmeister LJ, Anderson KL, Daily S, Beenken KE, Roux CM, Reniere ML, Lewis TL, Weiss WJ, Pulse M, Nguyen P, Simecka JW, Morrison JM, Sayood K, Asojo OA, Smeltzer MS, Skaar EP, Dunman PM. 2011. Small molecule inhibitors of Staphylococcus aureus RnpA alter cellular mRNA turnover, exhibit antimicrobial activity, and attenuate pathogenesis. PLoS Pathog. 7:e1001287. doi:10.1371/journal.ppat.1001287.